Pages that link to "Q80204825"
Jump to navigation
Jump to search
The following pages link to Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques (Q80204825):
Displaying 20 items.
- Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity (Q24642027) (← links)
- Synthetic DNA vaccine strategies against persistent viral infections (Q27016078) (← links)
- Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus (Q27487330) (← links)
- Vaccines: the Fourth Century (Q27490454) (← links)
- Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells (Q28481556) (← links)
- Evaluation of a novel non-penetrating electrode for use in DNA vaccination (Q28740588) (← links)
- Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. (Q30360232) (← links)
- Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans. (Q30372481) (← links)
- An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates. (Q30375785) (← links)
- Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine. (Q30378897) (← links)
- Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. (Q30395101) (← links)
- Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review (Q30404393) (← links)
- Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model (Q30414135) (← links)
- Fusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilities (Q31152863) (← links)
- Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens (Q33346277) (← links)
- Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment (Q33507532) (← links)
- Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation (Q33555860) (← links)
- Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device (Q33586294) (← links)
- Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments (Q33713435) (← links)
- Optimization of intradermal vaccination by DNA tattooing in human skin (Q33792008) (← links)